PSIL Holdings Information

PSIL is an equity ETF with a total of 30 individual holdings. The top holdings are AtaiBeckley stock at 10.74%, Definium Therapeutics at 8.72%, COMPASS Pathways at 8.56%, Supernus Pharmaceuticals at 7.50%, and Relmada Therapeutics at 6.81%.

Total Holdings

Top 10 Percentage

69.73%

Asset Class

Equity

ETF Category

Miscellaneous Sector

Assets

21.03M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ATAI	AtaiBeckley Inc.	10.74%	567,587
2	DFTX	Definium Therapeutics, Inc.	8.72%	108,901
3	CMPS	COMPASS Pathways plc	8.56%	255,739
4	SUPN	Supernus Pharmaceuticals, Inc.	7.50%	31,453
5	RLMD	Relmada Therapeutics, Inc.	6.81%	353,872
6	GHRS	GH Research PLC	6.39%	79,334
7	ALKS	Alkermes plc	5.98%	37,269
8	NBIX	Neurocrine Biosciences, Inc.	5.26%	8,070
9	CSE: DRUG	Bright Minds Biosciences Inc.	4.94%	11,813
10	NRXP	NRx Pharmaceuticals, Inc.	4.84%	470,467
11	ANRO	Alto Neuroscience, Inc.	4.52%	56,823
12	CYBN.NE	Helus Pharma Inc Ordinary Shares	3.86%	108,604
13	STIM	Neuronetics, Inc.	3.67%	342,193
14	JNJ	Johnson & Johnson	3.63%	3,378
15	ABBV	AbbVie Inc.	3.50%	3,265
16	NEUP	Neuphoria Therapeutics Inc.	2.92%	148,627
17	CSE: QNTM	Quantum BioPharma Ltd.	1.66%	63,591
18	KTTA	Pasithea Therapeutics Corp.	1.41%	337,508
19	IXHL	Incannex Healthcare Inc.	1.18%	735,097
20	SILO	Silo Pharma, Inc.	1.16%	663,965
21	TSX: NUMI	Numinus Wellness Inc.	1.03%	5,359,413
22	VTGN	Vistagen Therapeutics, Inc.	0.84%	277,110
23	n/a	Blackrock Treasury Trust Instl 62	0.45%	93,028
24	ENVB	Enveric Biosciences, Inc.	0.34%	16,974
25	CMND	Clearmind Medicine Inc.	0.10%	7,357

Showing 25 of 30 holdings

Subscribe to see the full list

Activate Now

As of Jan 26, 2026